Giunti Psychometrics Holding SpA (FRA:0ZD) 1-Year Sharpe Ratio: N/A (As of Sep. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0ZD Giunti Psychometrics Holding SpA FRA:0ZD
13 GF Score
Price €4.25
View Full Analysis

What is Giunti Psychometrics Holding SpA 1-Year Sharpe Ratio?

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-09-01), Giunti Psychometrics Holding SpA's 1-Year Sharpe Ratio is Not available.

Giunti Psychometrics Holding SpA  (FRA:0ZD) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Giunti Psychometrics Holding SpA 1-Year Sharpe Ratio Related Terms

FRA:0ZD vs ABT, SYK, MDT: 1-Year Sharpe Ratio Comparison

For the Medical Devices subindustry, Giunti Psychometrics Holding SpA's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Giunti Psychometrics Holding SpA 1-Year Sharpe Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Giunti Psychometrics Holding SpA's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Giunti Psychometrics Holding SpA's 1-Year Sharpe Ratio falls into.


FRA:0ZD
13GF Score
Giunti Psychometrics Holding SpA FRA:0ZD
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Giunti Psychometrics Holding SpA 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Giunti Psychometrics Holding SpA Business Description

Other Exchanges GPSY:Italy
Address Via Fra Paolo Sarpi 7/A, Firenze, ITA, 50136
Giunti Psychometrics Holding SpA operates internationally in the field of psychological assessment. The company designs, develops, and distributes tools and methodologies for psychologicaland psycho-aptitude assessment, used in various fields, including clinical practice (clinical and health psychology, child psychiatry and neuropsychiatry, neuropsychology and speech therapy), human resources management (work and organizational psychology), and education and guidance (level assessment tests, tools for diagnosing learning difficulties, and tools for school, university, and career guidance). The majority of revenue is derived from sales in the mental health and clinical area.
13GF Score

Get the complete analysis for FRA:0ZD

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.25
Price